ISIN
ES0157097017
Ticker
ALM
Sector
Sub-Industry
Country
Spain
Year Founded
1943
Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their lives. Our noble purpose guides our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and pioneering medical dermatology products to bring our innovative solutions to patients in need.
1,765
Worldwide
Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Assets | N/A | 2,291,114,000.00 | 2,141,744,000.00 | 2,147,691,000.00 |
Noncurrent Assets | N/A | 1,801,364,000.00 | 1,642,470,000.00 | 1,594,973,000.00 |
Property Plant And Equipment | N/A | 113,548,000.00 | 117,413,000.00 | 124,051,000.00 |
Goodwill | N/A | 315,966,000.00 | 315,966,000.00 | 315,966,000.00 |
Intangible Assets Other Than Goodwill | N/A | 1,009,536,000.00 | 916,056,000.00 | 898,677,000.00 |
Deferred Tax Assets | N/A | 256,476,000.00 | 192,500,000.00 | 182,971,000.00 |
Other Noncurrent Financial Assets | N/A | N/A | 80,502,000.00 | 34,655,000.00 |
Current Assets | N/A | 489,750,000.00 | 499,274,000.00 | 552,718,000.00 |
Inventories | N/A | 130,151,000.00 | 118,632,000.00 | 130,095,000.00 |
Trade And Other Current Receivables | N/A | 111,295,000.00 | 127,671,000.00 | 138,261,000.00 |
Current Tax Assets Current | N/A | N/A | 34,054,000.00 | 20,817,000.00 |
Other Current Financial Assets | N/A | 6,025,000.00 | 899,000.00 | 443,000.00 |
Other Current Nonfinancial Assets | N/A | 9,991,000.00 | 11,531,000.00 | 14,722,000.00 |
Cash and cash equivalents | 117,293,000.00 | 165,667,000.00 | 207,386,000.00 | 248,823,000.00 |
Equity And Liabilities | N/A | 2,291,114,000.00 | 2,141,744,000.00 | 2,147,691,000.00 |
Equity | 1,280,186,000.00 | 1,302,966,000.00 | 1,286,039,000.00 | 1,318,715,000.00 |
Issued Capital | N/A | 21,374,000.00 | 21,573,000.00 | 21,782,000.00 |
Share Premium | N/A | 273,889,000.00 | 295,785,000.00 | 317,315,000.00 |
Statutory Reserve | N/A | 4,189,000.00 | 4,275,000.00 | 4,275,000.00 |
Noncurrent Liabilities | N/A | 513,589,000.00 | 574,712,000.00 | 554,363,000.00 |
Noncurrent Provisions For Employee Benefits | N/A | 85,641,000.00 | 77,883,000.00 | 54,046,000.00 |
Other Longterm Provisions | N/A | 35,899,000.00 | 24,505,000.00 | 20,746,000.00 |
Deferred Tax Liabilities | N/A | 117,382,000.00 | 75,852,000.00 | 77,254,000.00 |
Other Noncurrent Financial Liabilities | N/A | 224,345,000.00 | 359,692,000.00 | 350,758,000.00 |
Other Noncurrent Nonfinancial Liabilities | N/A | 19,434,000.00 | 22,618,000.00 | 17,624,000.00 |
Current Liabilities | N/A | 474,559,000.00 | 280,993,000.00 | 274,613,000.00 |
Trade And Other Current Payables | N/A | 162,143,000.00 | 177,800,000.00 | 184,287,000.00 |
Current Tax Liabilities Current | N/A | 21,460,000.00 | 19,471,000.00 | 26,643,000.00 |
Other Current Financial Liabilities | N/A | 248,300,000.00 | 12,314,000.00 | 12,402,000.00 |
Other Current Nonfinancial Liabilities | N/A | 36,394,000.00 | 65,130,000.00 | 46,181,000.00 |
Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|
Revenue | 807,427,000.00 | 827,195,000.00 | 863,248,000.00 |
Other Income | 7,062,000.00 | 9,305,000.00 | 15,263,000.00 |
Other Work Performed By Entity And Capitalised | 4,941,000.00 | 8,932,000.00 | 7,539,000.00 |
Raw Materials And Consumables Used | 177,442,000.00 | 181,752,000.00 | 189,324,000.00 |
Other Employee Expense | 177,004,000.00 | 188,420,000.00 | 201,660,000.00 |
Depreciation And Amortisation Expense | 123,085,000.00 | 119,937,000.00 | 120,636,000.00 |
Other Expense By Nature | 229,005,000.00 | 247,584,000.00 | 307,788,000.00 |
Profit Loss From Operating Activities | 92,298,000.00 | 5,752,000.00 | 46,866,000.00 |
Finance Income | 1,579,000.00 | 493,000.00 | 637,000.00 |
Finance Costs | 18,003,000.00 | 20,600,000.00 | 12,785,000.00 |
Profit Loss Before Tax | 79,238,000.00 | -9,085,000.00 | 31,027,000.00 |
Income Tax Expense Continuing Operations | 4,958,000.00 | 31,774,000.00 | 26,746,000.00 |
Profit (loss) | 74,280,000.00 | -40,859,000.00 | 4,281,000.00 |
Profit Loss Attributable To Owners Of Parent | 74,280,000.00 | -40,859,000.00 | 4,281,000.00 |
Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Profit (loss) | N/A | 74,280,000.00 | -40,859,000.00 | 4,281,000.00 |
Adjustments For Finance Costs | N/A | 18,003,000.00 | 20,600,000.00 | 12,785,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | 25,329,000.00 | -13,338,000.00 | 10,695,000.00 |
Adjustments For Depreciation And Amortisation Expense | N/A | 123,085,000.00 | 119,937,000.00 | 120,636,000.00 |
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | -16,197,000.00 | -90,844,000.00 | 0.00 |
Adjustments For Provisions | N/A | 3,195,000.00 | -3,357,000.00 | 2,285,000.00 |
Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | -742,000.00 | 2,044,000.00 | 1,984,000.00 |
Adjustments For Fair Value Gains Losses | N/A | 4,106,000.00 | 3,218,000.00 | -5,675,000.00 |
Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | -649,000.00 | -13,871,000.00 | -4,863,000.00 |
Cash Flows From Used In Operating Activities | N/A | 112,757,000.00 | 233,852,000.00 | 155,102,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 11,891,000.00 | 18,814,000.00 | 23,007,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 64,635,000.00 | 52,338,000.00 | 93,473,000.00 |
Interest Received Classified As Investing Activities | N/A | 1,082,000.00 | 28,000.00 | 170,000.00 |
Cash Flows From Used In Investing Activities | N/A | -23,517,000.00 | -57,255,000.00 | -68,543,000.00 |
Payments To Acquire Or Redeem Entitys Shares | N/A | 82,000.00 | -596,000.00 | -46,000.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 16,882,000.00 | 154,488,000.00 | 10,000,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 8,289,000.00 | 7,772,000.00 | 7,200,000.00 |
Dividends Paid Classified As Financing Activities | N/A | 2,129,000.00 | 11,746,000.00 | 12,419,000.00 |
Interest Paid Classified As Financing Activities | N/A | 6,536,000.00 | 6,130,000.00 | 9,899,000.00 |
Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | -6,948,000.00 | 251,000.00 | -5,650,000.00 |
Cash Flows From Used In Financing Activities | N/A | -40,866,000.00 | -134,878,000.00 | -45,122,000.00 |
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 48,374,000.00 | 41,719,000.00 | 41,437,000.00 |
Cash and cash equivalents | 117,293,000.00 | 165,667,000.00 | 207,386,000.00 | 248,823,000.00 |
Please note that some sums might not add up.
ES0157097017
95980020140005007996
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.